Survey finds kidney cancer patients face anxiety over delayed scan results
Findings revealed that 66% of patients are waiting at least three weeks after their scan for results
Read More
Tag: Kidney Cancer UK
Kidney cancer charity slams NICE rejection of Keytruda/Inlyta
NICE says the combination’s cost-effectiveness estimate is higher than what is considered acceptable for NHS use
Read More
Half of all kidney cancer patients initially misdiagnosed
Half of all patients with kidney cancer are initially misdiagnosed, data from Kidney Cancer UK’s patient survey has revealed.
Read More
Survey reveals low awareness of kidney cancer
A charity survey has highlighted an “urgent need” for earlier diagnosis of kidney cancer, revealing that, in 51 percent of cases, the disease is detected from scans relating to other health conditions.
Read More
- NICE backs daratumumab quadruplet for newly diagnosed transplant‑ineligible myeloma
- Anocca doses first patients with precision TCR‑T therapy
- Connecta launches phase 2a trial of neuroplasticity modulator
- Aquipta recommended by NICE for acute migraine treatment
- Talvey accepted for use in Scotland for relapsed and refractory multiple myeloma
